2026 NPPES data Family Medicine Physician NPI 1275732976 M.D.
Verify on CMS →

MANI KHOSHNEJAD, M.D.

Family Medicine Physician in BAYTOWN, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 320 beneficiaries · Family Medicine Physician avg: 3K
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
88.1864/100
▲ 5 pts above national avg 83.1 · [object Object]
Industry payments
$1.8K
106 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MANI KHOSHNEJAD, M.D. reported a CMS MIPS final score of 88.1864/100 — above the 83.1 national average — and filed 3,829 Medicare Part D claims in 2023.

88.1864/100
MIPS score · +5 vs avg
4K
Part D claims, 2023
86%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MANI KHOSHNEJAD, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

88 Top 44% higher than 56% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MANI KHOSHNEJAD, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MANI KHOSHNEJAD, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 07/12/2007

NPI 1275732976

Primary specialty

Family Medicine Physician

High-volume

147,640 US NPIs in this specialty

Medicare Part D claims

3,829 12% vs specialty avg

2023 prescription claims

Specialty avg: 3,418

MIPS final score

88.1864/100 5.086400000000012% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Texas

How Family Medicine Physician compares to other specialties among Texas providers

Texas providers

Family Medicine Physician share within Texas

1. Family Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Family Medicine Physician share within Texas

Medicare quality performance — MIPS

MANI KHOSHNEJAD, M.D.'s 2023 MIPS final score plotted against the Family Medicine Physician national average

High performer (top quartile)
MIPS Final Score
88.1864/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Family Medicine Physician) — 88.1864/100 vs national avg 83.1

0%100%National avg83%88.2%
MIPS final score (Family Medicine Physician) — 88.1864/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MANI KHOSHNEJAD, M.D. appears in the CMS NPPES registry as a Family Medicine Physician provider holding M.D. credentials at 2223 ROLLINGBROOK DR., BAYTOWN, TX, 77521, with a listed phone of (281) 420-3565. NPI 1275732976 was issued on 07/12/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KHOSHNEJAD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,829 prescription claims written by this provider, covering 320 Medicare beneficiaries and totaling roughly $633K in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 0.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 88.1864/100 for the 2023 performance year (Quality 87.405, Cost 77.4145), compared with the national average of 83.1.

Family Medicine Physician is a high-volume specialty nationwide, with 147,640 enrolled providers across 56 states and an average of 3,418 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2223 ROLLINGBROOK DR.
BAYTOWN, TX 77521

Provider Details

NPI 1275732976
Specialty Family Medicine Physician
Credentials M.D.
Gender Male
NPI Issued 07/12/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

88.1864
Final Score
Avg: 83.1
87.405
Quality
77.4145
Cost

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MANI KHOSHNEJAD, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.8K

Largest payer

Novo Nordisk Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to MANI KHOSHNEJAD, M.D.. To verify MANI KHOSHNEJAD, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MANI KHOSHNEJAD, M.D. — brand share 14.0%
Specialty average (est.)

14% brand-name claims vs 86% generic, on 3,829 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,829
Total Claims
$633K
Total Drug Cost
320
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,251
Total Day Supply
232,549
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$566K
Generic Drug Cost
$66K
Opioid Claims
31 (0.8% rate)
Antibiotic Claims
281

Patient Demographics

Average Patient Age
71.9 years
Avg HCC Risk Score
0.99
Gender Split
58% female / 42% male
Age Distribution
<65: 15, 65-74: 201, 75-84: 85, 85+: 19

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MANI KHOSHNEJAD, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Rosuvastatin Calcium
156
Levothyroxine Sodium
125
Prednisone
124
Azithromycin
122
Amlodipine Besylate
98
Atorvastatin Calcium
91
Lisinopril
83
Hydrochlorothiazide
80
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
80
Pantoprazole Sodium
79

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Family Medicine Physician Overview

How MANI KHOSHNEJAD, M.D. fits within the Family Medicine Physician landscape nationally.

147,640
Family Medicine Physician Providers in US
56
States with Family Medicine Physician
3,418
Avg Claims per Provider

MANI KHOSHNEJAD, M.D.'s 3,829 claims are above the specialty average of 3,418.

Nearby Family Medicine Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as KHOSHNEJAD.

Compare Family Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MANI KHOSHNEJAD, M.D.'s specialty?
MANI KHOSHNEJAD, M.D. specializes in Family Medicine Physician and practices in BAYTOWN, Texas. Credentials: M.D..
How much does MANI KHOSHNEJAD, M.D. prescribe under Medicare Part D?
In 2023, MANI KHOSHNEJAD, M.D. wrote 3,829 Medicare Part D claims totaling $633K in drug costs for 320 beneficiaries.
What is MANI KHOSHNEJAD, M.D.'s Medicare quality score?
MANI KHOSHNEJAD, M.D. has a CMS MIPS Final Score of 88.1864/100 (Quality: 87.405, Cost: 77.4145). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MANI KHOSHNEJAD, M.D. located?
MANI KHOSHNEJAD, M.D. is located at 2223 ROLLINGBROOK DR., BAYTOWN, TX, 77521. Phone: (281) 420-3565.
What is MANI KHOSHNEJAD, M.D.'s NPI number?
MANI KHOSHNEJAD, M.D.'s National Provider Identifier (NPI) is 1275732976, issued on 07/12/2007.
Does MANI KHOSHNEJAD, M.D. prescribe more brand-name or generic drugs?
MANI KHOSHNEJAD, M.D.'s prescribing is 14% brand-name and 86% generic drugs by claim count, with $566K in brand drug costs.
Does MANI KHOSHNEJAD, M.D. prescribe opioids?
Yes, MANI KHOSHNEJAD, M.D. had 31 opioid claims in 2023 with an opioid prescribing rate of 0.8%.
How many Family Medicine Physician providers are there in the US?
There are 147,640 Family Medicine Physician providers across 56 states in the US. The average Family Medicine Physician provider writes 3,418 Medicare Part D claims per year.
What drugs does MANI KHOSHNEJAD, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MANI KHOSHNEJAD, M.D.'s most frequently prescribed drugs include Rosuvastatin Calcium, Levothyroxine Sodium, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MANI KHOSHNEJAD, M.D. accept Medicare?
MANI KHOSHNEJAD, M.D. appears in CMS Medicare data with 3,829 Part D claims and 320 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MANI KHOSHNEJAD, M.D.'s credentials?
MANI KHOSHNEJAD, M.D.'s NPI is 1275732976 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology